We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 133.00
Bid: 130.00
Ask: 136.00
Change: 0.00 (0.00%)
Spread: 6.00 (4.615%)
Open: 131.00
High: 133.00
Low: 131.00
Prev. Close: 133.00
NBS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Tender Offer

23 Feb 2023 15:43

RNS Number : 8980Q
Nationwide Building Society
23 February 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN (1) THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (THE UNITED STATES), (2) THE REPUBLIC OF ITALY, OR (3) ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

Nationwide Building Society announces final results of

its inaugural Open Market Repurchase Exercise

in respect of its Core Capital Deferred Shares

23 February 2023.  On 20 February 2023, Nationwide Building Society (Nationwide) announced (i) the launch of an open market repurchase facility (the OMR Facility) under which it may, from time to time and in its sole discretion, seek to repurchase limited numbers of the Core Capital Deferred Shares of £1 nominal amount each (ISIN: GB00BBQ33664) (the CCDS) issued by Nationwide and (ii) the commencement of the inaugural open market repurchase exercise under the OMR Facility (the OMR Exercise 2023-1).

The OMR Exercise 2023-1 was made on the terms and subject to the conditions contained in the announcement made by Nationwide on 20 February 2023 (the Launch Announcement). Capitalised terms used, but not defined, in this announcement have the meanings given to them in the Launch Announcement.

The Second OMR Tender Period expired at 3.00 p.m. (London time) on 23 February 2023, and Nationwide announces today the final results of the OMR Exercise 2023-1.

Final Results of OMR Exercise 2023-1

Nationwide announces that it has decided to set the Second OMR Acceptance Amount at 387,804 CCDS, and that Nationwide will accordingly accept for purchase CCDS validly tendered during the Second OMR Tender Period subject to application of a Scaling Factor of 65.01 per cent., as described in the Launch Announcement.

The expected settlement date for CCDS validly tendered during, and accepted for purchase in connection with, the Second OMR Tender Period is 27 February 2023 (the Second OMR Settlement Date).

On the Second OMR Settlement Date, holders of CCDS validly tendered for purchase during the Second OMR Tender Period and accepted for purchase will receive, for each CCDS purchased, an amount equal to the aggregate of (i) the Purchase Price of £128.93 per CCDS and (ii) an Amount Attributable to Potential Future Distributions of £1.94 per CCDS.

Following settlement on the Second OMR Settlement Date, Nationwide will have purchased an aggregate of 775,608 CCDS pursuant to the OMR Exercise 2023-1. Nationwide intends to hold all such CCDS purchased by it pursuant to the OMR Exercise 2023-1 in treasury, and future re-sales of any purchased CCDS may occur from time to time at the sole discretion of Nationwide. The Conditions of the CCDS provide that any such re-sale will not be subject to pre-emption rights.

Summary

Description of the CCDS

ISIN

Second OMR Acceptance Amount

Scaling Factor

Aggregate number of CCDS purchased by Nationwide pursuant to the OMR Exercise 2023-1

Aggregate number of CCDS outstanding following the OMR Exercise 2023-1

Nationwide's Core Capital Deferred Shares of £1 nominal amount each

GB00BBQ33664

387,804 CCDS

65.01 per cent.

775,608 CCDS

9,779,892 CCDS*

* This figure excludes the CCDS purchased by Nationwide pursuant to the OMR Exercise 2023-1, which (for so long as they are held by Nationwide in treasury) will be deemed not to be outstanding for certain purposes under the Conditions of the CCDS.

UBS AG London Branch (Telephone: +44 20 7568 1121; Attention: Liability Management Group; Email: ol-liabilitymanagement-eu@ubs.com) is acting as Dealer Manager in connection with the OMR Exercise 2023-1.

LEI of Nationwide Building Society: 549300XFX12G42QIKN82

DISCLAIMER

This announcement must be read together with the Launch Announcement. No offer or invitation to acquire any securities is being made pursuant to this announcement.

The distribution of this announcement and the Launch Announcement in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Launch Announcement come(s) are required by Nationwide and the Dealer Manager to inform themselves about, and to observe, any such restrictions.

The OMR Exercise 2023-1 has now expired and no additional CCDS will be accepted for purchase pursuant to the OMR Exercise 2023-1.

This announcement is made by Nationwide, and the Dealer Manager does not accept any responsibility for the contents of this announcement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTEDZGZZKFZGFZM
Date   Source Headline
30th Apr 20244:47 pmRNSForm 8.3 - Virgin Money UK plc
25th Apr 20248:40 amRNSPre Stabilisation Notice - Nationwide dual covered
23rd Apr 202411:33 amRNSForm 8.3 - Virgin Money UK PLC
23rd Apr 202411:28 amRNSForm 8.3 - Virgin Money UK PLC
22nd Apr 20247:00 amRNSPublication of Scheme Document
17th Apr 20243:05 pmRNSForm 8.3 - Virgin Money UK plc
12th Apr 20243:53 pmRNSPublication of Final Terms
11th Apr 20243:58 pmRNSForm 8.5 (EPT/NON-RI) - Virgin Money UK Plc 25 Mar
5th Apr 20243:44 pmRNSPublication of Suppl.Prospcts
28th Mar 20241:50 pmRNSForm 8.5 (EPT/RI) - Virgin Money UK Plc 26 Mar
28th Mar 20241:47 pmRNSForm 8.5 (EPT/RI) - Virgin Money UK PLC 25 Mar
25th Mar 202412:43 pmRNSForm 8.5 (EPT/RI) - Virgin Money Uk Plc
25th Mar 202412:40 pmRNSForm 8.5 (EPT/RI) - Virgin Money UK Plc
25th Mar 202412:39 pmRNSForm 8.5 (EPT/RI) - Virgin Money UK Plc
21st Mar 202411:55 amRNSForm 8 - Nationwide Building Society - Replacement
21st Mar 20247:00 amRNSRecommended cash offer for Virgin Money UK PLC
19th Mar 202411:37 amRNSForm 8.5 (EPT/RI) - Virgin Money Uk Plc 14 MAR
19th Mar 202411:36 amRNSForm 8.5 (EPT/RI) - Virgin Money UK Plc
19th Mar 202411:31 amRNSForm 8.5 (EPT/RI) - Virgin Money UK Plc 15 Mar
19th Mar 202411:30 amRNSForm 8.5 (EPT/RI) - Virgin Money Uk Plc 14 Mar
19th Mar 202411:29 amRNSForm 8.5 (EPT/RI) - Virgin Money UK Plc 13 MAR
19th Mar 202411:28 amRNSForm 8.5 (EPT/RI) - Virgin Money UK Plc 12 MAR
19th Mar 202411:26 amRNSForm 8.5 (EPT/RI) - Virgin Money Uk Plc 11 MAR
19th Mar 202411:24 amRNSForm 8.5 (EPT/RI) - Virgin Money UK Plc 8 MAR
15th Mar 20243:14 pmRNSForm 8 (OPD) (Nationwide Building Society))
8th Mar 20243:54 pmRNSForm 8.5 (EPT/RI) - Virgin Money
7th Mar 20247:00 amRNSJoint Statement Re Potential Cash Acquisition
27th Dec 20237:00 amRNSPost Stabilisation Notice - Nationwide
8th Dec 20233:53 pmRNSPublication of Supplementary Prospectus
27th Nov 20234:34 pmRNSPublication of Final Terms
17th Nov 20232:15 pmRNSPublication of Suppl.Prospcts
17th Nov 20237:00 amRNSHalf-year Report
10th Nov 20232:45 pmRNSPublication of Final Terms
9th Nov 20232:45 pmRNSPublication of Final Terms
7th Nov 20237:00 amRNSPublication of Suppl.Prospcts
30th Oct 20235:36 pmRNSPublication of Final Terms
30th Oct 20237:00 amRNSPublication of Final Terms
24th Oct 20233:03 pmRNSPublication of Final Terms
20th Oct 20235:11 pmRNSPublication of a Prospectus
17th Oct 202310:44 amRNSPublication of Final Terms
2nd Oct 202310:25 amRNSRedemption of Notes
27th Sep 20233:50 pmRNSPublication of Final Terms
15th Sep 202311:02 amRNSPublication of a Prospectus
4th Sep 202310:49 amRNSPublication of Final Terms
4th Sep 202310:49 amRNSPublication of Final Terms
17th Aug 20235:49 pmRNSPublication of Final Terms
16th Aug 20234:43 pmRNSPublication of Final Terms
14th Aug 20234:19 pmRNSPublication of Final Terms
10th Aug 20233:23 pmRNSPublication of Final Terms
8th Aug 20234:15 pmRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.